1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > PharmaPoint: Parkinson’s Disease - Current and Future Players

PharmaPoint: Parkinson’s Disease - Current and Future Players

Summary

GlobalData has released its pharma report, “PharmaPoint: Parkinson’s Disease - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Parkinson’s Disease Market. The report identifies and analyses the key companies shaping and driving the global Parkinson’s Disease market. The report provides insight into the competitive Parkinson’s Disease landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.

Scope

- Investigation of current and future market competition for Parkinson’s Disease
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of Parkinson’s Disease sector through market impact analysis, future market scenario and company analysis

Reasons to buy

- Gain a high level view of the trends shaping and driving Parkinson’s Disease market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- What’s the next big thing in the global Parkinson’s Disease market landscape? Identify, understand and capitalize

Table Of Contents

PharmaPoint: Parkinson’s Disease - Current and Future Players
1 Table of Contents

2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 9
3 Market Outlook 12
3.1 Global Markets 12
3.1.1 Forecast 12
3.1.2 Drivers and Barriers - Global Issues 16
4 Current and Future Players 19
4.1 Overview 19
4.2 Trends in Corporate Strategy 20
4.3 Company Profiles 21
4.3.1 Merck 21
4.3.2 Roche 23
4.3.3 AbbVie 25
4.3.4 UCB 27
4.3.5 GlaxoSmithKline 28
4.3.6 Novartis 30
4.3.7 Orion 33
4.3.8 Newron 35
4.3.9 Civitas 36
4.3.10 Impax 38
4.3.11 Lundbeck 40
5 Appendix 43
5.1 Bibliography 43
5.2 Abbreviations 47
5.3 Methodology 49
5.4 Forecasting Methodology 49
5.4.1 Diagnosed Parkinson's disease Patients 49
5.4.2 Percent Drug-Treated Patients 50
5.4.3 General Pricing Assumptions 50
5.4.4 Compliance Assumptions 51
5.4.5 Generic Erosion 51
5.5 Physicians and Specialists Included in this Study 52
5.6 About the Authors 54
5.6.1 Author 54
5.6.2 Global Head of Healthcare 55
5.7 About GlobalData 56
5.8 Disclaimer 56

1.1 List of Tables

Table 1: Global Sales Forecasts ($m) for Parkinson's Disease, 2012-2022 14
Table 2: Parkinson's Disease Market - Drivers and Barriers, 2012-2022 16
Table 3: Key Companies in the Parkinson's Market, 2014 19
Table 4: Merck's Parkinson's Disease Portfolio Assessment, 2014 23
Table 5: Merck's PD SWOT Analysis, 2014 23
Table 6: Roche's Parkinson's Disease Portfolio Assessment, 2014 25
Table 7: Roche's PD SWOT Analysis, 2014 25
Table 8: AbbVie's Parkinson's Disease Portfolio Assessment, 2014 26
Table 9: AbbVie's PD SWOT Analysis, 2014 26
Table 10: UCB's Parkinson's Disease Portfolio Assessment, 2014 27
Table 11: UCB's PD SWOT Analysis, 2014 28
Table 12: GSK's Parkinson's Disease Portfolio Assessment, 2014 30
Table 13: GSK's PD SWOT Analysis, 2014 30
Table 14: Novartis' Parkinson's Disease Portfolio Assessment, 2014 32
Table 15: Novartis' PD SWOT Analysis, 2014 32
Table 16: Orion's Parkinson's Disease Portfolio Assessment, 2014 34
Table 17: Orion's PD SWOT Analysis, 2014 34
Table 18: Newron's Parkinson's Disease Portfolio Assessment, 2014 36
Table 19: Newron's PD SWOT Analysis, 2014 36
Table 20: Civitas' Parkinson's Disease Portfolio Assessment, 2014 37
Table 21: Civitas' PD SWOT Analysis, 2014 38
Table 22: Impax's Parkinson's Disease Portfolio Assessment, 2014 40
Table 23: Impax's PD SWOT Analysis, 2014 40
Table 24: Lundbeck's Disease/Therapy Portfolio Assessment, 2014 42
Table 25: Lundbeck's SWOT Analysis, 2014 42

1.2 List of Figures

Figure 1: Global Sales for Parkinson's Disease by Region, 2012-2022 15
Figure 2: Company Portfolio Gap Analysis in Parkinson's Motor Symptoms, 2012-2022 20

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Parkinson%s Disease  - Market Insights, Epidemiology and Market Forecast-2023

Parkinson%s Disease  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Parkinson’s Disease - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and ...

EpiCast Report: Schizophrenia - Epidemiology Forecast to 2025

EpiCast Report: Schizophrenia - Epidemiology Forecast to 2025

  • $ 3995
  • Industry report
  • November 2016
  • by Global Data

EpiCast Report: Schizophrenia - Epidemiology Forecast to 2025 Summary Schizophrenia is a severe mental disorder that affects an individual’s behaviors, thoughts, and emotions; it is extremely heterogeneous, ...

Parkinson%s Disease  - Epidemiology Forecast To 2023

Parkinson%s Disease  - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight “Parkinson's Disease  - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Parkinson's Disease  in seven major markets (US, France, Germany, Italy, Spain, ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.